BSE filing, NSE: LACTOSE. Summary written from the filing by ALFA Finder's alert engine.
Lactose (India) Ltd: key numbers
- Share price
- ₹106.40
- Market cap
- ₹133.9 Cr
- Revenue (annual)
- ₹163.3 Cr
- Net profit (annual)
- ₹6.06 Cr
- P/E (TTM)
- 19.3×Sector 46.1×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lactose (India) Ltd
All →Lactose (India) Acquisition
Lactose (India) fixed November 2, 2026 as record date for the NCLT-approved amalgamation with Vitanosh Ingredients at a 0.7946 share exchange ratio.
Lactose (India) Other Announcement
Lactose India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Lactose (India) Other Announcement
Lactose India Ltd has appointed Alpesh A. Lakeshri as the Cost Auditor for the financial year 2026-27.
Lactose (India) Annual General Meeting
Lactose (India) Limited concluded its 35th Annual General Meeting, where shareholders approved financial statements, director appointments, remuneration revisions, and related party transactions.
Lactose (India) Annual General Meeting
Lactose (India) Limited announced its 35th Annual General Meeting to be held on September 30, 2026, along with relevant book closure and e-voting schedules.
Lactose (India) Annual Report
Lactose (India) Limited has filed its 35th Annual Report for the financial year 2025-26 with the stock exchange.
Other acquisition announcements
All →Laurus Labs Acquisition Worth ₹32.5 Cr
Laurus Labs approved acquiring 52% of SI & C Resins for Rs. 32.50 Crore. The acquisition makes SI&C a subsidiary for peptide resin manufacturing.
- Value
- ₹32.50 Cr
Laurus Labs Acquisition Worth ₹35.63 Cr
Laurus Labs approved buying 60% of Canada-based CRO Galenvs Sciences for USD 3.75 million (₹35.63 Cr). The deal adds an oligonucleotide R&D arm and North American presence.
- Value
- ₹35.63 Cr
Raghav Productivity Enhancers Acquisition
RPEL acquires 80% of RPEL TRLK Silicatech Private Limited for a nominal cash subscription. The target manufactures silica ramming mass and other refractories in India.
Container Corporation of India Acquisition Worth ₹485.9 Cr
CONCOR placed an order with Braithwaite & Co for 24 rakes of BLSS wagons. The deal, including GST, values at Rs.485.93 Crores.
- Value
- ₹485.9 Cr
- Execution
- Delivery by 20.06.2028
- BLSS wagons (fleet)
- 24.0 rakes
Embassy Developments Acquisition Worth ₹32.65 Cr
Embassy Developments signed an SPA to acquire 50% of Embassy Columbia Pacific ASL for ₹32.65 Crore. The JV will become wholly owned upon closing by December 2026.
- Value
- ₹32.65 Cr
- Execution
- Within the current quarter ending on December 31, 2026
MosChip Technologies Acquisition Worth ₹266.7 Cr
MosChip will acquire Vayavya Labs for Rs.266.71 Crore in cash and shares. Completion awaits RBI and exchange approvals and shareholder approval of a preferential issue.
- Value
- ₹266.7 Cr
- Execution
- Within 15 days of the later of receipt of all requisite approvals or shareholder approval of the preferential issue to VLPL sellers